Logo.png
Interpace Diagnostics Announces Presentation at the World Congress on Thyroid Cancer
June 13, 2019 06:55 ET | Interpace Diagnostics Group, Inc.
Rome, ITALY, June 13, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG), a fully integrated bioinformatics and commercial molecular diagnostic company, today announced that...
IDXG Logo.jpg
Interpace Diagnostics BarreGEN® Data to be Presented at Digestive Disease Week
May 09, 2019 06:55 ET | Interpace Diagnostics Group, Inc.
Company to Host Fellowship and Key Opinion Leader Programs PARSIPPANY, NJ, May 09, 2019 (GLOBE NEWSWIRE) --  Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that data from an...
IDXG Logo.jpg
Interpace Diagnostics Group Reports Full Year and Fourth Quarter 2018 Financial Results
March 19, 2019 16:05 ET | Interpace Diagnostics Group, Inc.
Business Progress and Recent Accomplishments Highlighted and Discussed Further on Conference Call PARSIPPANY, NJ, March 19, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:...
IDXG Logo.jpg
Interpace Diagnostics Announces Preliminary 2018 Revenues
February 28, 2019 06:55 ET | Interpace Diagnostics Group, Inc.
Interpace to Host Fourth Quarter and Full Year 2018 Results Conference Call/Webcast PARSIPPANY, NJ, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
IDXG Logo.jpg
Interpace Diagnostics Announces First Independent Publication Demonstrating Clinical Utility of BarreGEN®
February 19, 2019 06:55 ET | Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that BMJ Open Gastroenterology, an on-line, peer-reviewed, open access...
IDXG Logo.jpg
Interpace Diagnostics Enters into Agreement with University of Maryland Medical System
January 14, 2019 06:55 ET | Interpace Diagnostics Group, Inc.
Agreement Provides Access to Company’s Available Molecular Diagnostic Tests PARSIPPANY, NJ, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) has entered in to an...
IDXG Logo.jpg
INTERPACE DIAGNOSTICS ANNOUNCES PARTICIPATION AT THE 20TH ANNUAL GLOBAL INVESTMENT CONFERENCE SPONSORED BY H.C.WAINWRIGHT & CO.
August 27, 2018 08:30 ET | Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...